Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ONO-4538 Phase II/III Study A Multicenter, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer

NCT02746796 is registered in ClinicalTrials.gov with Ono Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02746796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02746796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ONO-4538 Phase II/III Study A Multicenter, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer
Lead sponsor
Ono Pharmaceutical Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2016
Completion date
November 17, 2022
Enrollment
680 (estimated)
Sites
130

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer